Global surveillance of oral tobacco products: Total nicotine, unionised nicotine and tobacco-specific N-nitrosamines

Tobacco Control

Volumn 20, Issue 3, 2011, Pages 1-10

  Stanfill, Stephen B ^a   Connolly, Gregory N ^b   Zhang, Liqin ^a   Jia, Lily T ^a   Henningfield, Jack E ^c   Richter, Patricia ^d   Lawler, Tameka S ^a   Ayo Yusuf, Olalekan A ^e   Ashley, David L ^a   Watson, Clifford H ^a  

^a NATIONAL CENTER FOR ENVIRONMENTAL HEALTH   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^e UNIVERSITY OF PRETORIA   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN; NICOTINE; NITROSAMINE;

ARTICLE; CHEMISTRY; HEALTH; HUMAN; INFRARED SPECTROSCOPY; PH; SMOKELESS TOBACCO;

CARCINOGENS; HUMANS; HYDROGEN-ION CONCENTRATION; NICOTINE; NITROSAMINES; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; TOBACCO, SMOKELESS; WORLD HEALTH;

EID: 79955586900     PISSN: 09644563     EISSN: 14683318     Source Type: Journal    
DOI: 10.1136/tc.2010.037465     Document Type: Article

References (26)

1. International Agency for Research on Cancer. Monograph 89: Smokeless Tobacco and Some Tobacco specific N-Nitrosamines 2007. http://monographs.iarc.fr/ENG/Monographs/vol89/index.php (accessed 8 Jul 2010).
2. Hatsukami DK, Ebbert JO, Feuer RM, et al. Changing Smokeless Tobacco Products: New Tobacco-Delivery Systems. Am J Prev Med 2010;33:S368e78.
3. Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR). Opinion on: Health Effects of Smokeless Tobacco Products. Taken from 22nd plenary meeting of 6 February 2008. 2008. http://ec.europa.eu/health/ph_risk/committees/09_scenihr/scenihr_opinions_en.htm#5 (accessed 8 Jul 2010).
4. World Health Organization. Advisory Note on Smokeless Tobacco Products: Health Effects, Implications for Harm Reduction and Research, In The Scientific Basis of Tobacco Product Regulation, Second Report of a WHO Study Group. WHO Technical Report Series, No. 951. Geneva: WHO, 2008:1e16.
5. Third International Conference on Smokeless Tobacco. Smokeless tobacco fact sheets. Stockholm, Sweden. 2002. http://cancercontrol.cancer.gov/tcrb/stfact_sheet_combined10-23-02.pdf (accessed 8 Jul 2010).
6. International Agency for Research on Cancer. Monograph 85: Betel-quid and Areca-nut Chewing and Some Tobacco specific N-Nitrosamines 2004. http://monographs.iarc.fr/ENG/Monographs/vol85/index.php (accessed 8 Jul 2010).
7. Fant RV, Henningfield JE, Nelson RA, et al. Pharmacokinetcis and pharmacodynamics of moist snuff in humans. Tob Control 1999;8:387e92.
8. Tomar SL, Henningfield JE. Review of the evidence that pH is a determinant of nicotine dosage from oral use of smokeless tobacco. Tob Control 1997;6:219e25.
9. Food and Drug Administration. Regulations restricting the sale and distribution of cigarettes and smokeless tobacco to protect children and adolescents; final rule. Fed Regist 1996;61:44396e5318. 21 CFR Part 801, et al.
10. International Agency for Research on Cancer. Agents classified by the IARC monographs, volumes 1e100. 2010. http://monographs.iarc.fr/ENG/Classification/ClassificationsAlphaOrder.pdf (accessed 8 Jul 2010).
11. Stepanov I, Jensen J, Hatsukami D, et al. New and traditional smokeless tobacco: Comparison of toxicant and carcinogen levels. Nic Tob Res 2008;10:1773e82.
12. Richter P, Hodge K, Stanfill S, et al. Surveillance of moist snuff: total nicotine, moisture, pH, un-ionized nicotine, and tobacco-specific nitrosamines. Nic Tob Res 2008;10:1645e52.
13. Hecht SS, Carmella SG, Murphy SE, et al. Similar Exposure to Tobacco-Specific Carcinogens in Smokeless Tobacco Users and Cigarette Smokers. Cancer Epidemio Biomarkers 2007;16:1567e72.
14. Gupta PC, Ray CS. Smokeless tobacco and health in India and South Asia. Respirology 2003;8:419e31.
15. Bhide SV, Kulkarni JR, Padma PR, et al. Studies on tobacco specific nitrosamines and other carcinogenic agents in smokeless tobacco products. In: Sanghvi LD, Notani PP, eds. Tobacco and Health: The Indian Scene. Proceedings of the UICC workshop, 'Tobacco or Health', April 15-16, 1987. Bombay: Tata Memorial Centre, 1989:9e15.
16. Sinha DN. Report on Oral Tobacco Use and its Implications in South East Asia. World Health Organization SEARO, 2004:3.
17. Idris AM, Nair J, Ohshima H, et al. Unusually high levels of carcinogenic tobaccospecific nitrosamines in Sudan snuff (toombak). Carcinogenesis 1991;12:1115e18.
18. Idris AM, Nair J, Friesen M, et al. Carcinogenic tobacco-specific nitrosamines are present at unusually high levels in the saliva of oral snuff users in Sudan. Carcinogenesis 1992;13:1001e5.
19. Stanfill SB, Jia LT, Watson CH, et al. Rapid and chemically-selective quantification of nicotine in smokeless tobacco products using gas chromatography/mass spectrometry. J Chromatogr Sci 2009;47:902e9.
20. Department of Health and Human Services, Centers for Disease Control and Prevention. Notice Regarding Revisions to the Laboratory Protocol To Measure the Quantity of Nicotine Contained in Smokeless Tobacco Products Manufactured, Imported, or Packaged in the United States. Fed Regis 2008;35 395e35 402. FR Doc. E8e14151.
21. Swedish Match corporate website. Gothia Tek product quality standard. http://www.swedishmatch.com/en/Snus-and-health/Our-quality-standard-GothiaTek (accessed 8 Jul 2010).
22. Department of Health and Human Services (US). Reducing tobacco use: a report of the Surgeon General. Washington: DHHS, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2000.
23. World Health Organization. WHO Study Group on Tobacco Product Regulation: Report on the Scientific Basis of Tobacco Product Regulation, WHO Technical Report Series, No. 955. Geneva: WHO Press, 2010.
24. Food and Drug Administration. FDA & Tobacco Regulation: Family Smoking Prevention and Tobacco Control Act of 2009. http://www.govtrack.us/congress/%20bill.xpd?bill=h111e1256 (assessed 8 Jul 2010).
25. Rodgman A, Perfetti TA. The chemical components of tobacco and tobacco smoke. Boca Raton, FL: CRC Press, 2009:55e110, 487e547, 687e720.
26. Ashley DL, O'Connor RJ, Bernert JT, et al. Effects of differing levels of tobaccospecific nitrosamines in cigarette smoke on the levels of biomarkers in smokers. Cancer Epidemiol Biomarkers Prev 2010;19:1389e98.